Heuron Inc.
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Evaluation of Heuron CTA for Detecting Suspected Large Vessel Occlusion Using Brain CT Angiography
Role: lead
Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
Role: lead
Prospective Study for Neuromelanin Image Analysis
Role: lead
Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images
Role: lead
Evaluation of Clinical Decision Support System for Large Vessel Occlusion Using Brain CT Images
Role: lead
Evaluation of Clinical Decision Support System for Scoring of ASPECT Score Using Brain CT Images
Role: lead
Evaluation of Clinical Decision Support System for Intracranial Hemorrhage Using Brain CT Images
Role: lead
All 7 trials loaded